DOLORES LOPEZ-TERRADA to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications DOLORES LOPEZ-TERRADA has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.021
-
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol. 2010 Apr 01; 28(10):1772-9.
Score: 0.021